Valuation: AVRA Medical Robotics, Inc.

Market Cap 716M 629M 582M 536M 1.01B 68.94B 1.02B 6.95B 2.72B 33.81B 2.69B 2.63B 117B P/E 2026 *
-59.7x
P/E 2027 * -59.7x
Enterprise Value 716M 629M 582M 536M 1.01B 68.94B 1.02B 6.95B 2.72B 33.81B 2.69B 2.63B 117B EV / Sales 2026 *
12.1x
EV / Sales 2027 * 9.53x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 51.19M
-0.18%-4.18%-1.02%+2.10% 48.71B
+1.61%-0.36%+378.56%+583.41% 38.35B
+2.61%+4.84%+8.19%+65.22% 34.53B
-1.12%-2.86%+25.52%-10.93% 34.03B
-0.58%-2.00%-0.07%+31.08% 26.77B
+1.37%-3.78% - - 15.64B
+0.71%+0.28%+70.48%+115.34% 15.08B
-2.03%+0.23%+13.53%+15.87% 14.18B
+0.26%+0.31%+16.08%-32.65% 12.73B
Average -0.09%-1.04%+63.91%+96.18% 26.67B
Weighted average by Cap. +0.40%-1.36%+76.11%+119.16%

Financials

2026 *2027 *
Net sales 59.4M 52.11M 48.29M 44.41M 83.81M 5.72B 84.88M 576M 225M 2.8B 223M 218M 9.69B 75.2M 65.97M 61.13M 56.23M 106M 7.24B 107M 730M 285M 3.55B 282M 276M 12.27B
Net income -12M -10.53M -9.75M -8.97M -16.93M -1.15B -17.15M -116M -45.54M -566M -45.05M -44.07M -1.96B -14M -12.28M -11.38M -10.47M -19.75M -1.35B -20.01M -136M -53.13M -661M -52.55M -51.42M -2.28B
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-